Litcius/Paper detail

EZH2 inhibition for epithelioid sarcoma and follicular lymphoma

Roman Groisberg, Vivek Subbiah

2020The Lancet Oncology19 citationsDOI

Topics & Concepts

MedicineOncologyClinical trialInternal medicineSarcomaFollicular lymphomaEpithelioid sarcomaSMARCB1Cancer researchLymphomaEpigeneticsPathologyBiologyGeneChromatin remodelingBiochemistryChromatin Remodeling and CancerSarcoma Diagnosis and TreatmentTumors and Oncological Cases
EZH2 inhibition for epithelioid sarcoma and follicular lymphoma | Litcius